FR2343476A2 - Compsns. contg. ethyl piperidine raubasinate - have vasoregulating, cardiotonic and hypertensive activity - Google Patents
Compsns. contg. ethyl piperidine raubasinate - have vasoregulating, cardiotonic and hypertensive activityInfo
- Publication number
- FR2343476A2 FR2343476A2 FR7607159A FR7607159A FR2343476A2 FR 2343476 A2 FR2343476 A2 FR 2343476A2 FR 7607159 A FR7607159 A FR 7607159A FR 7607159 A FR7607159 A FR 7607159A FR 2343476 A2 FR2343476 A2 FR 2343476A2
- Authority
- FR
- France
- Prior art keywords
- contg
- raubasinate
- compsns
- vasoregulating
- cardiotonic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
Abstract
Pharmaceutical compsns. contg. N-beta-ethyl piperidine raubasinate (I) or a pharmaceutically acceptable salt, are new. (I) is prepared, as described in the parent patent, either by treating raubasinic acid with N-2-chloroethyl piperidine, or by transesterifying a raubasine ester using an alkali metal N-2-hydroxyethyl piperidine alcoholate. In a typical example, tablets were prepd. contg. 0.05 0g (I.hydrochloride) 0.045g potato starch, 0.002g of a fatty acid ester, 0.002g talc, and 0.001 g scarlet G.N.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7607159A FR2343476A2 (en) | 1976-03-12 | 1976-03-12 | Compsns. contg. ethyl piperidine raubasinate - have vasoregulating, cardiotonic and hypertensive activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7607159A FR2343476A2 (en) | 1976-03-12 | 1976-03-12 | Compsns. contg. ethyl piperidine raubasinate - have vasoregulating, cardiotonic and hypertensive activity |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2343476A2 true FR2343476A2 (en) | 1977-10-07 |
FR2343476B2 FR2343476B2 (en) | 1979-06-15 |
Family
ID=9170334
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7607159A Granted FR2343476A2 (en) | 1976-03-12 | 1976-03-12 | Compsns. contg. ethyl piperidine raubasinate - have vasoregulating, cardiotonic and hypertensive activity |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2343476A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2422664A1 (en) * | 1978-04-14 | 1979-11-09 | Synthelabo | Tetra:hydro:alstonine ester and amide derivs. - with anti:anoxic, psychotropic and antidepressant activity (BE 15.10.79) |
-
1976
- 1976-03-12 FR FR7607159A patent/FR2343476A2/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2422664A1 (en) * | 1978-04-14 | 1979-11-09 | Synthelabo | Tetra:hydro:alstonine ester and amide derivs. - with anti:anoxic, psychotropic and antidepressant activity (BE 15.10.79) |
Also Published As
Publication number | Publication date |
---|---|
FR2343476B2 (en) | 1979-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5484084A (en) | Storage stabilizing agent of microorganism and production and use thereof | |
IE780433L (en) | N, n-diaryl-malonamide and diaryl methyl¹sulphinylacetamides. | |
AU512934B2 (en) | Unsaturated derivatives of 7-acylamido-3-cephem 4-carboxyclic acid | |
ZA787399B (en) | Medicine with activity as prostaglandin synthetase inhibitor | |
FR2343476A2 (en) | Compsns. contg. ethyl piperidine raubasinate - have vasoregulating, cardiotonic and hypertensive activity | |
ES474975A1 (en) | Preparation of 6,11-dihydro-11-oxodibenz{8 b,e{9 oxepin-2-acetic acid and precursors therefor | |
GB1514389A (en) | Glycerides with antibacterial properties | |
AU3340384A (en) | Hydroxyethylazolyl - oxime derivatives | |
GB1261989A (en) | 5-thiazolecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing the same | |
GB1498919A (en) | Furanose-o-pyridylcarboxylic acid esters | |
ES458764A1 (en) | Indolyl acetic acid derivative | |
JPS5221387A (en) | Process for preparing a novel lipase | |
SU596577A1 (en) | N-methyl-n'-4-(5-amino-1,2,4-triazolyl-3)-butyl/-thiourea showing antihistaminic activity and method of obtaining same | |
IL54015A0 (en) | Novel prostaglandin-like cyclobutane derivatives and process for their manufacture | |
NZ187182A (en) | 2-trichloromethyl-4-nitrobenzene-sulphenic acid derivatives and combatting fungi and bacteria | |
JPS5436291A (en) | Preparation of theobromine derivative | |
DE2861128D1 (en) | Esters of n-pyrimidinyl-carboximidic acid, process for their preparation and medicines containing them. | |
ES436058A1 (en) | O-Alkyl-O-n-propyl-O-pyrimidin(2)yl-thiono-phosphoric acid esters | |
JPS5435280A (en) | Preparation of yeast cells | |
AU546903B2 (en) | Heterogeneous reactor and process | |
FR2324303A2 (en) | Pharmaceutical compsn. contg. nicotinamide-(N)-ethyl nicotinate - for treatment of disorders caused by hyperlipidemia | |
ES462071A1 (en) | Pyrimidine derivative | |
JPS53148588A (en) | Accerelation of cellulose fermentation | |
AU513202B2 (en) | Furoyl and. thenoyl-aryoxyalkyl carboxylic acid derivatives | |
ES468457A1 (en) | Physiologically active peptides and a process for the preparation thereof |